{
  "nct_id": "NCT71839257",
  "indication": "COPD",
  "phase": "Phase 3",
  "sample_size": 462,
  "duration_weeks": 28,
  "dropout_rate": 0.31,
  "blinding": "double-blind",
  "control_arm": "placebo",
  "primary_endpoints": [
    "Exacerbation reduction"
  ],
  "secondary_endpoints": [
    "SGRQ score improvement",
    "FEV1 improvement"
  ],
  "outcome_summary": "Statistically significant improvement on primary and key secondary endpoints",
  "success": 1,
  "start_date": "2020-11-29",
  "completion_date": "2021-06-13"
}